It is difficult to proceed with a project with subdivided quasi-drugs.
✅ Wadiz Funding for Quasi-drugs
It is difficult to proceed because manufacturing or providing unreported quasi-drugs may be punished under the Pharmaceutical Affairs Act. Therefore, you cannot proceed with a project with rewards that have been repackaged or changed in packaging from finished quasi-drugs.